常茂生物(00954.HK)签订关闭搬迁协议 搬迁补偿合计2.05亿元
格隆汇9月28日丨常茂生物(00954.HK)发布公告,于2020年9月28日,公司与由常州市新北区春江镇人民政府委任的政府代表,即常州市正安房屋拆迁有限公司,签订关于相关工厂区的关闭搬迁的关闭搬迁协议。
关闭有关物业坐落于江苏省常州市新北区长江北路1228号,总占地面积为55,600.75平方米,总建筑面积为23,216.5平方米的相关工厂区。关闭搬迁补偿合计人民币2.05亿元。
公司的目标是尽快完成关闭搬迁,并恢复生产,以最大程度地减少暂时中断生产对集团的影响。关于顺酐的供应,公司目前正在从第三方购买,直到恢复生产为止。据公司所知,由于市场供应减少,自2020年九月上旬以来,顺酐的现行市场价格已出现显著上涨。公司认为,如果顺酐的价格保持较高水平,或继续增长,导致销售成本增加,集团于2020年下半年或第四季度的财务表现可能受到不利影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.